Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Gastroenterology | Immunology | Family Medicine
Ulcerative Colitis Clinical Trials
A listing of Ulcerative Colitis medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham : University of Alabama at Birmingham
An Open-label Study of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease
Birmingham : University of Alabama at Birmingham
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Birmingham : Apex Clinical Trials
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Dothan : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Dothan : Digestive Health Specialists of the Southeast
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Mobile : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Mobile : Horizon Research Group, Inc.
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Mobile : Internal Medicine Center, LLC
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Mobile : Springhill Memorial Hospital
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Mobile :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Arizona
Phoenix :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Scottsdale : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Sun City : Investigational Site Number 840065
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Tucson : Adobe Surgery Center
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Tucson : Adobe Clinical Research, LLC
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Arkansas
Little Rock : Lexicon Investigational Site
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Little Rock : Arkansas Children's Hospital
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
California
Los Angeles : Gastrointestinal Bioscience
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Los Angeles : Cedars-Sinai Medical Center
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Montebello : Paramount Medical Specialty
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Sacramento : Capital Gastroenterology Consultants Medical Group
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
San Diego : Desta Digestive Disease Medical Center
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
San Diego : Clinical Applications Laboratories Inc.
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Anaheim : Lexicon Investigational Site
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Anaheim :
Efficacy and Safety Study of RPC1063 in Ulcerative Colitis
Anaheim : Anaheim Clinical Trials
Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis
Anaheim : Santarus Clinical Investigational Site 1043 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Anaheim : Advanced Clinical Research Institute
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
Francisco :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Glendale : Research Site
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis
Glendale : Research Site
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.
La Jolla : UCSD Medical Center
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
La Jolla : UCSD Medical Center
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Lakewood : Santarus Clinical Investigational Site 1071 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Los Angeles : Cedars Sinai Medical Center
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Los Angeles : Cedars-Sinai Medical Center
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Los Angeles : Investigational Site Number 840031
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Los Angeles : Cedars Sinai Medical Center
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
Los Angeles : Cedars-Sinai Medical Center
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
Los Angeles : Cedars-Sinai Medical Center - Inflammatory Bowel Disease Center
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
Los Angeles : Santarus Clinical Investigational Site 1051 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Los Angeles :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Mission Hills : Investigational Site Number 840059
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Oakland :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Palm Springs : Homan A Zadeh, MD, MPH
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Palm Springs : Homan A Zadeh, MD, MPH
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Rancho Mirage : Hope Square Surgical Center
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
San Diego : Sharp Rees-Stealy Medical Group
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
San Diego : Clinical Application Laboratories, Inc.
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
San Diego : San Diego Endoscopy Center
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
San Diego : Investigational Site Number 840074
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
San Diego : Sharp Rees-Stealy Medical Group
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
San Diego : Santarus Clinical Investigational Site 1003 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
San Diego : Santarus Clinical Investigational Site 1053 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
San Diego :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
San Francisco : University of California, San Francisco
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
Colorado
Aurora : University of CO Health Sciences Center
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Lafayette : Gastroenterology of the Rockies
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Lakewood : Rocky Mountain Gastroenterology Associates P.L.L.C.
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Littleton : Arapahoe Gastroenterology Associates P.C
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Lone Tree : South Denver Gastroenterology
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Pueblo : Lynn Institute of Pueblo
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Denver :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Lakewood : Rocky Mountain Gastroenterology
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Lakewood, : Investigational Site Number 840030
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Littleton : Investigational Site Number 840061
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Littleton : Santarus Clinical Investigational Site 1063 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Connecticut
Hamden : Gastroenterology Center of Connecticut, P.C.
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Bristol : Santarus Clinical Investigational Site 1028 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Giolford : Endoscopy Center of Connecticut, LLC
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Guilford : Endoscopy Center of Connecticut, LLC
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Guilford : Endoscopy Center of Connecticut, LLC
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
Hamden : Gastroenterology Center of Connecticut, PC
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Hamden : Endoscopy Center of Connecticut, LLC
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Hamden : Medical Research Center of Connecticut, LLC
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Hamden : Endoscopy Center of Connecticut, LLC
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Hamden : Gastroenterology Center of Connecticut, PC
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Hamden : Medical Research Center of Connecticut, LLC
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Hamden : Pfizer Investigational Site
A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis
Hamden : Endoscopy Center of Connecticut, LLC
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
Hamden : Gastroenterology Center of Connecticut, LLC
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
Hamden : Medical Research Center of Connecticut, LLC
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
Hamden : Santarus Clinical Investigational Site 1018 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Hartford : Connecticut Children's Medical Center
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
Hartford :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
New Haven :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Florida
Gainesville : University of Florida
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Jacksonville : Borland-Groover Clinic
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Jacksonville : University of Florida, Jacksonville
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Jacksonville : East Coast Institute for Research
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Melbourne : Osler Clinical Research
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Miami : University of Miami Miller School of Medicine
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
New Smyrna Beach : United Medical Research Institute
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Orlando : Internal Medicine Specialists
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Orlando : Compass Research LLC
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Palm Harbor : Advanced Gastroenterology Associates
Ulcerative Colitis
Port Orange : Accord Clinical Research, LLC
Ulcerative Colitis
Tampa : University of South Florida
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Tampa : West Wind'r Research & Development, LLC
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Winter Park : Shafran Gastroenterology Center
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Boynton : Santarus Clinical Investigational Site 1035 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Boynton Beach : Investigational Site Number 840054
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Clearwater : Investigational Site Number 840050
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Cooper City : South Broway Ebdiscopy
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Crystal River : Pfizer Investigational Site
A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis
Dundin : North Pinellas Surgery Center
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Gainesville :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Hialeah : Pfizer Investigational Site
A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis
Hialeah : Digestive Medical Associates
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Hollywood : Southern Clinical Research Consultants
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Inverness : Pfizer Investigational Site
A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis
Jacksonville : Santarus Clinical Investigational Site 1045 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Largo : Santarus Clinical Investigational Site 1001 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Maitland : Center for Advanced Gastroenterology
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Maitland : MNH Surgical Center
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Maitland : Investigational Site Number 840041
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Maitland : Santarus Clinical Investigational Site 1024 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Miami : Jackson Memorial Hospital
Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease
Miami :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Miami : Research Site
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.
Miramar : Santarus Clinical Investigational Site 1013 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Miramar, : Investigational Site Number 840008
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Naples : Gastroenterology Group of Naples
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Naples : Gastroenterology Group of Naples
Dose Escalation and Remission (DEAR)
Naples : Investigational Site Number 840044
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Orlando : Internal Medicine Specialists
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Orlando : Citrus Ambulatory Surgery Center
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Orlando : Pfizer Investigational Site
A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis
Palm Harbor : Advanced Gastroenterology Associates, LLC
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Palm Harbor : West Coast Radiology
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Palm Harbor : Advanced Gastroenterology Associates
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Port Orange : Santarus Clinical Investigational Site 1029 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Tampa : West Wind'r Research & Development, LLC
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Winter Park : Shafran Gastroenterology Center
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Winter Park : Shafran Gastroenterology Center
Dose Escalation and Remission (DEAR)
Winter Park : Santarus Clinical Investigational Site 1010 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Winter Park : Shafran Gastroenterology
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Winter Park, : Investigational Site Number 840048
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Zephyrhills : Florida Medical Clinic
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Zephyrhills : Florida Medical Clinic
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Zephyrhills : Florida Medical Clinic
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
Zephyrhills : Santarus Clinical Investigational Site 1002 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Georgia
Atlanta : Atlanta Gastroenterology Associates
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Decatur : Atlanta Center for Gastroenterology, P.C.
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Macon : Gastroenterology Associates of Central Georgia
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Newnan : Digestive Research Associates
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Savannah : St. Joseph's/Candler Health System
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Snellville : DLW Research System
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Agusta : Investigational Site Number 840073
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Alpharetta : Georgia Endoscopy Center
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Alpharetta : Georgia Endoscopy Center
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Alpharetta : Georgia Endoscopy Center
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
Athens : Tri-County Research
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Atlanta : GI Consultants
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Atlanta : GI Consultants
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Atlanta : Atlanta Gastroenterology Associates
Dose Escalation and Remission (DEAR)
Atlanta :
Efficacy and Safety Study of RPC1063 in Ulcerative Colitis
Atlanta : GI Consultants
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
Atlanta :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Atlanta :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Decatur : Atlanta Center for Gastroenterology, P.C.
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Decatur : Santarus Clinical Investigational Site 1050 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Decatur : The Atlanta Center for Gastroenterology
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Johns Creek : Emory Healthcare Heart Center
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Johns Creek : Emory Healthcare Heart Center
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Johns Creek : Emory Healthcare Heart Center
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
Macon : Gastroenterology Associates of Central Georgia, LLC
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Macon : Gastroenterology Associates of Central Georgia, LLC
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Macon : Gastroenterology Associates of Central Georgia, LLC
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
Marietta : Santarus Clinical Investigational Site 1085 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Savannah, : Investigational Site Number 840053
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Suwanee : Atlanta Gastroenterology Associates
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Suwanee : Johns Creek Diagnostic Center
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Suwanee : Atlanta Gastroenterology Associates
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Suwanee : Johns Creek Diagnostic Center
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Suwanee : Pfizer Investigational Site
A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis
Suwanee : Atlanta Gastroenterology Associates
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
Idaho
Boise :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Illinois
Chicago : Rush University Medical Center - Treatment Research Center
Dysbiosis in inflammatory bowel disease.
Urbana : Carle Clinic Association P.C.
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Arlington Heights : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Arlington Heights : NCH Medical Group
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Chicago : Investigational Site Number 840001
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Chicago : Santarus Clinical Investigational Site 1075 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Chicago :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Oak Lawn : Southwest Gastroenterology
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Oak Lawn : Investigational Site Number 840005
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Oak Lawn : Santarus Clinical Investigational Site 1065 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Indiana
Indianapolis : Santarus Clinical Investigational Site 1058 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Iowa
Clive : Iowa Digestive Disease Center
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Clive : Digestive & Liver Consultants
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Clive : Santarus Clinical Investigational Site 1008 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Davenport : Gastrointestinal Clinic of Quad Cities
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Kansas
Kansas City : University Of Kansas
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Topeka : Cotton O'Neil Digestive Health Center
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Topeka : Cotton-O'Neil Clinical Research Center, Digestive Health
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Wichita : Professional Research Network of Kansas
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Kentucky
Lexington : University of Kentucky Medical Center
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Louisville : University Of Louisville
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Louisiana
Baton Rouge : Gastroenterology Associates
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Hammond : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Hammond : Investigational Site Number 840078
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Metairie : Santarus Clinical Investigational Site 1034 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
New Orleans :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Shreveport : Santarus Clinical Investigational Site 1032 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Maine
Portland :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Maryland
Baltimore : University of Maryland Medical Group
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Chevy Chase : Metropolitan Gastroenterology Group, P.C.
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Chevy Chase : Metropolitan Gastroenterology Group, PC Chevy Chase Clinical Research
Ulcerative Colitis and Crohn’s Disease (IBD) Research Study
Prince Frederick : Shah Associates
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Annapolis : Santarus Clinical Investigational Site 1044 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Baltimore : University of Maryland Medical Center
Dose Escalation and Remission (DEAR)
Chevy Chase : Metropolitan Gastroenterology Group, PC - Chevy Chase Clinical Research
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Chevy Chase : Chevy Chase Clinical Research
Dose Escalation and Remission (DEAR)
Chevy Chase :
Efficacy and Safety Study of RPC1063 in Ulcerative Colitis
Chevy Chase : Chevy Chase Clinical Research
Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis
Chevy Chase : Santarus Clinical Investigational Site 1057 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Hollywood : Investigational Site Number 840049
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Hollywood : Santarus Clinical Investigational Site 1012 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Prince Frederick : Shah Associates, MD, LLC
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Massachusetts
Boston : Boston Medical Center
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Boston : Massachusetts General Hospital
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Boston :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Worcester :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Michigan
Dearborn : The Center for Clinical Studies
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Troy : Center for Digestive Health
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Wyoming : Gastroenterology Associates of Western Michigan, P.L.C.
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Ann Arbor : University of Michigan Health Systems - A. Alfred Taubman Health Care Center
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Ann Arbor : University of Michigan Health Systems - A. Alfred Taubman Health Care Center
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Ann Arbor :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Berkley : Dr. Jason Bozdin, M.D.
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Chesterfield : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Chesterfield : Clinical Research Institute of Michigan, LLC
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Chesterfield : Clinical Research Institute of Michigan, LLC
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Chesterfield : Clinical Research Institute of Michigan
Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis
Chesterfield : Santarus Clinical Investigational Site 1016 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Detroit :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Novi : Santarus Clinical Investigational Site 1081 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Troy : Center for Digestive Health
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Troy : Center for Digestive Health
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Troy : Center for Digestive Health
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
Utica : Utica Surgery Center (Endoscopy ONLY)
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Wyoming : Investigational Site Number 840011
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Wyoming : Santarus Clinical Investigational Site 1015 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Wyoming : Gregory Cammel, MD PLC
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Ypsilanti : Santarus Clinical Investigational Site 1068 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Minnesota
Plymouth : Minnesota Gastroenterology, P.A.
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Rochester : Mayo Clinic
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Minneapolis :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Plymouth : Minnesota Gastroenterology, P.A.
Dose Escalation and Remission (DEAR)
Rochester : Mayo Clinic
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Rochester : Mayo Clinic
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Rochester : Santarus Clinical Investigational Site 1074 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Rochester : Mayo Clinic
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
Rochester :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Rochester :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Saint Paul :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Mississippi
Jackson : GI Associates and Endoscopy Center
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Ocean Springs : Investigational Site Number 840060
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Missouri
Kansas City : Truman Medical Center
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Mexico : Center for Digestive and Liver Diseases, Inc.
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
St. Louis : Washington University
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
St. Louis : St. Louis Center for Clinical Research
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Columbia : Surgery Center of Columbia
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Hannibal : Hannibal Regional Hospital
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Mexico : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Mexico : Center for Digestive & Liver Disease, Inc.
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Mexico : Audrain Medical Center
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Mexico : Investigational Site Number 840024
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Mexico : Center for Digestive and Liver Disease
Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis
Nebraska
Boys Town :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
New Hampshire
Lebanon : Dartmouth-Hitchcock Medical Center
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Lebanon : Santarus Clinical Investigational Site 1061 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Manchester :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
New Jersey
Morristown : Affiliates in Gastroenterology PA
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
New Brunswick : University of Medicine and Dentistry of New Jersey-NJMS
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Vineland : The Gastroenterology Group of South Jersey
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Egg Harbour Township : AGA Clinical Research Associates, LLC
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Marlton : South Jersey Gastroenterology
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Marlton : South Jersey Gastroenterology
Dose Escalation and Remission (DEAR)
Mays Landing :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Morristown :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Vineland : The Gastroenterology Group of South Jersey
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Vineland : The Gastroenterology Group of South Jersey
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Vineland : The Gastroenterology Group of South Jersey
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
New York
Bayside : Hepatobiliary Associates of New York
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Cheektowaga : Digestive Health Physician
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Great Neck : Long Island Clinical Research Associates
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Merrick : Long Island Gastroenterology Group, P.C.
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
New York : The Rockefeller University Hospital
Inflammatory Bowel Disease Exacerbation and Changes in Gut Microbiome and Innate Immunity
New York : Present Chapman Marion Steinlauf MD PC
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
New York : New York Presbyterian Hospital
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Pittsford : Kim, Chung MD (Private Practice)
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Rochester : University of Rochester
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Setauket : Long Island Digestive Disease Consultants
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Stonybrook : SUNY Stony Brook University Medical Center
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Syracuse : Syracuse Gastroenterological Associates
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Brooklyn :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Buffalo :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Cheektowaga : Santarus Clinical Investigational Site 1021 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Great Neck : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Great Neck : Long Island Clinical Research Associates, LLP
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Great Neck : Nassau Gastroenterology Associates, PC
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Great Neck : Nassau Gastroenterology Associates
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Great Neck : Lexicon Investigational Site
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Great Neck : Investigational Site Number 840051
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Great Neck :
Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Great Neck : Santarus Clinical Investigational Site 1027 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Great Neck : Santarus Clinical Investigational Site 1072 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Great Neck : Long Island Clinical Research Associates, LLP
Safety, Efficacy, and Tolerability Study of ASP3291 in Patients With Active Ulcerative Colitis
Great Neck : Long Island Clinical Research Associates
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Great Neck :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Lake Success : Santarus Clinical Investigational Site 1067 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Mineola :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
New Hyde Park :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
New York : Santarus Clinical Investigational Site 1031 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
New York : Research Associates of New York
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
New York :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Stony Brook :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Syracuse :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
North Carolina
Chapel Hill : University of North Carolina at Chapel Hill
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Charlotte : Charlotte Gastroentology and Hepatology, P.L.L.C
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Elkin : Northwest Piedmont Clinical Research, Inc.
An Open-label Study of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease
Elkin : Northwest Piedmont Clinical Research, Inc.
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Morganton : Burke Research Associates
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Raleigh : Multi-Specialty Research Associates of NC
Do you have ulcerative colitis in remission?
Raleigh : Wake Research Associates
Struggling with Ulcerative Colitis?
View More »
Chapel Hill :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Davidson : Carolina Digestive Health Associates
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Durham :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Greensboro : LeBauer Endoscopy Center
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Greensboro : LeBauer HealthCare
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Greensboro : LeBauer Research Associates, P.A.
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Greenville : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Greenville : Carolina Research - Carolina Digestive Diseases
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Jacksonville, : Investigational Site Number 840018
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Wilmington : Santarus Clinical Investigational Site 1073 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Ohio
Cincinnati : Consultants for Clinical Research Inc.
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Dayton : Dayton Science Institute
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Cincinati : Santarus Clinical Investigational Site 1080 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Cincinnati : Investigational Site Number 840046
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Cincinnati :
Efficacy and Safety Study of RPC1063 in Ulcerative Colitis
Cincinnati :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Cleveland : Santarus Clinical Investigational Site 1078 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Columbus : Investigational Site Number 840006
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Columbus : Remington-Davis, Inc.
Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis
Dayton : Santarus Clinical Investigational Site 1082 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Mentor : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Mentor : Great Lakes Gastroenterology
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Mentor : Great Lakes Gastroenterology
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Mentor : Great Lakes Gastroenterology
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
Oklahoma
Tulsa : Options Health Research
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Norman : Central Sooner Research
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Oklahoma City : Oklahoma Foundation for Digestive Research
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Oklahoma City :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Tulsa : Lexicon Investigational Site
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Tulsa : Gastroenterology United Tulsa
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Tulsa : Options Health Research
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Oregon
Portland : The Oregon Clinic-West Hills Gastroenterology
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Pennsylvania
Pittsburgh : University of Pittsburgh Medical Center - Cancer Centers
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Danville :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Lancaster : Regional Gastroenterology Associates of Lancaster, Ltd.
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Lancaster : Santarus Clinical Investigational Site 1064 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Philadelphia : University of Pennsylvania - Presbyterian Medical Center
Dose Escalation and Remission (DEAR)
Philadelphia : University of Pennsylvania
Study of Cimzia for the Treatment of Ulcerative Colitis
Philadelphia :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Phoenixville : Investigational Site Number 840045
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Sayre : Donald Guthrie Foundation for Education and Research
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Sayre : Investigational Site Number 840022
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Sayre : Santarus Clinical Investigational Site 1006 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
South Carolina
Charleston : Medical University Of SC CAR
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Greenville :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Tennessee
Germantown : Gastroenterology Center of the MidSouth, PC
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Nashville : Vanderbilt University Medical Center
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Germantown : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Germantown : Memphis Gastroenterology Group
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Hermitage : Associates in Gastroenteroogy
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Hermitage : Hermitage Imaging
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Hermitage : Associated Endoscopy
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Knoxville :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Memphis :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Nashville : Inflammatory Bowel Disease Clinic c/o Divison of Gastroenterology, Hepatology and Nutrition, Department of Medicine, School of Medicine, Vanderbilt University
Decisional Influences and Inflammatory Bowel Disease (IBD) Patients' Medication Use
Nashville : Nashville Medical Research Institute
Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis
Texas
Austin : Austin Gastroenterology, PA
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Houston : Gastroenterology Consultants
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Houston : Jacon Medical Research Associates
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Houston : Baylor College Of Medicine
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Houston : Bayou City Research, Ltd.
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Pasadena : Digestive Health Center
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
San Antonio : Stone Oak Research Foundation
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Tyler : Digestive Health Specialists of Tyler
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Austin : Santarus Clinical Investigational Site 1059 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Dallas : Dallas VA Medical Center
Exacerbating Factors in Inflammatory Bowel Disease
Dallas : Dallas VA Medical Center
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Dallas :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Fort Worth :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Houston : Gastroenterology Consultants, P.A.
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Houston : Lexicon Investigational Site
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Houston : Santarus Clinical Investigational Site 1004 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Houston : Santarus Clinical Investigational Site 1019 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Houston : Santarus Clinical Investigational Site 1039 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Humble : Investigational Site Number 840072
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Pasadena : Pasadena Gastroenterology Associates, P.A. dba Digestive Health Center
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Pasadena : Santarus Clinical Investigational Site 1005 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Pasadena, : Investigational Site Number 840019
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
San Antonio : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
San Antonio : Lexicon Investigational Site
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Sugar Land : Investigational Site Number 840038
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
The Woodlands : Santarus Clinical Investigational Site 1048 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Tyler : Digestive Health Specialists of Tyler
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Tyler : Digestive Health Specialists of Tyler
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Tyler : Digestive Health Specialists of Tyler
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
Utah
Sandy : Granite Peaks Gastroenterology
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Lancaster : Santarus Clinical Investigational Site 1014 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Ogden : Lexicon Investigational Site
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Ogden : Santarus Clinical Investigational Site 1020 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Salt Lake City : Alpine Medical Group
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Salt Lake City : Wasatch Endoscopy Center
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Salt Lake City : Wasatch Clinical Research
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Salt Lake City : Alpine Medical Group
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Salt Lake City : Wasatch Clinical Research
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Salt Lake City : Wasatch Endoscopy Center
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
West Jordan : RGL Medical Services
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Vermont
Burlington :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Virginia
Charlottesville : University of Virginia Health System
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Chesapeake : Gastroenterology Associates of Tidewater
A Phase 2/3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of XXXXXXXXX Induction Therapy, Administered Subcutaneously, in Subjects with Moderately to Severely Active Ulcerative Colitis.
Fairfax : Gastroenterology Associates of Northern Virginia
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Norfolk : Digestive and Liver Disease Specialist Ltd
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Richmond : Hunter Holmes McGuire VA Medical Center
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Charlottesville : Investigational Site Number 840068
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Charlottesville :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Chesapeake : Santarus Clinical Investigational Site 1038 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Christianburg : Santarus Clinical Investigational Site 1025 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Fairfax :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Norfolk :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Washington
Edmonds : Puget Sound Medical Research
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Seattle : Lexicon Investigational Site
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Seattle : University of Washington
Study of Cimzia for the Treatment of Ulcerative Colitis
Seattle :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Wisconsin
Madison : Pharmaseek, LLC
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Milwaukee : Wisconsin Center for Advanced Research
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Milwaukee : Medical College Of Wisconsin
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
View More »
Madison : Santarus Clinical Investigational Site 1036 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Madison :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Milwaukee : Wisconsin Center for Advanced Research - GI Associates, LLC
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Milwaukee : Center for Digestive Health
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Milwaukee : Wisconsin Center for Advanced Research - GI Associates, LLC
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Milwaukee : Center for Digestive Health
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Milwaukee : Wisconsin Center for Advanced Research
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Milwaukee :
Study Registry to Evaluate the Long-term Safety of Infliximab and Clinical Status of Pediatric Patients With Inflammatory Bowel Disease
Wauwatosa : Investigational Site Number 840064
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
Australia
Adelaide : Research Site
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis
Adelaide : Research Site
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.
Concord : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Fitzroy :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Garran :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
View More »
Herston : Research Site
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis
Herston : Research Site
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.
Parkville :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Prahran : Research Site
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis
Prahran : Research Site
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.
Austria
Innsbruck : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Ried im Innkreis : Site Reference ID/Investigator# 66064
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
St Veit an der Glan : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
St. Poelten : Site Reference ID/Investigator# 66188
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Belgium
Bonheiden : Site Reference ID/Investigator# 61091
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Bonheiden : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Brussels : Site Reference ID/Investigator# 61093
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Brussels : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Gent : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
View More »
Ghent : Site Reference ID/Investigator# 61092
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Ghent : Site Reference ID/Investigator# 61089
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Kortrijk : Site Reference ID/Investigator# 63843
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Leuven : Site Reference ID/Investigator# 61096
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Leuven : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Leuven : Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Leuven : UZ Leuven
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Leuven : UZ Leuven
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Leuven : Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Leuven :
Efficacy and Safety Study of RPC1063 in Ulcerative Colitis
Leuven :
Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Leuven : UZ Leuven
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
Leuven : Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
Liège : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Liege : Site Reference ID/Investigator# 61094
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Roeselare : Site Reference ID/Investigator# 61090
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Bulgaria
Pleven : Santarus Clinical Investigational Site 4003 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Plovdiv : Santarus Clinical Investigational Site 4009 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Plovdiv : Santarus Clinical Investigational Site 4004 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Ruse : Santarus Clinical Investigational Site 4008 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Sofia :
A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis
View More »
Sofia : Santarus Clinical Investigational Site 4005 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Sofia : Santarus Clinical Investigational Site 4001 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Sofia : Santarus Clinical Investigational Site 4002 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Sofia : Santarus Clinical Investigational Site 4010 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Sofia : Santarus Clinical Investigational Site 4011 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Sofia : Santarus Clinical Investigational Site 4007 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Canada
Calgary : Site Reference ID/Investigator# 61408
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Guelph : Site Reference ID/Investigator# 64422
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Halifax : Site Reference ID/Investigator# 61406
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Halifax : Santarus Clinical Investigational Site 2008 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Hamilton : Site Reference ID/Investigator# 61407
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
View More »
London : Site Reference ID/Investigator# 61405
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
London : Santarus Clinical Investigational Site 2005 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
London : Santarus Clinical Investigational Site 2004 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
London :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Montreal : Santarus Clinical Investigational Site 2009 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Quebec : Santarus Clinical Investigational Site 2006 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Saskatoon : Site Reference ID/Investigator# 61762
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Sherbrooke : Santarus Clinical Investigational Site 2001 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Toronto : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Toronto : Toronto Digestive Disease Associates
Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis
Toronto :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Vancouver : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Vaughan : Santarus Clinical Investigational Site 2002 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Victoria : Site Reference ID/Investigator# 61409
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Winnipeg : Site Reference ID/Investigator# 61403
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Winnipeg : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Winnipeg : Santarus Clinical Investigational Site 2003 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
China
Beijing :
A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis
Chengdu :
A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis
Guangzhou :
A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis
Hefei :
A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis
Shanghai :
A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis
View More »
Wuhan :
A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis
Xian :
A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis
Croatia
Zagreb :
A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis
Czech Republic
Hradec Kralove : Research Sites 402 and 404
A clinical research study for patients 18 or older with Ulcerative Colitis
Ostrava : Research Sites 406 and 407
A clinical research study for patients 18 or older with Ulcerative Colitis
Prague : Research Sites 405 and 409
A clinical research study for patients 18 or older with Ulcerative Colitis
Slany : Research Site 403
A clinical research study for patients 18 or older with Ulcerative Colitis
Tabor : Research Site 401
A clinical research study for patients 18 or older with Ulcerative Colitis
View More »
Hradec Kralove : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Hradec Kralove : Santarus Clinical Investigational Site 3006 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Hradec Kralove : Santarus Clinical Investigational Site 3001 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Hradec Kralove :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Labem : Santarus Clinical Investigational Site 3005 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Nachod :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Olomouc : Santarus Clinical Investigational Site 3003 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Ostrava - Poruba :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Prague : Santarus Clinical Investigational Site 3009 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Praha : Santarus Clinical Investigational Site 3007 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Praha : Santarus Clinical Investigational Site 3004 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Praha 4 : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Praha 7 : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Tabor : Santarus Clinical Investigational Site 3002 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Usti nad Labem : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Usti nad Orlici : Santarus Clinical Investigational Site 3010 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Valasske Mezirici : Santarus Clinical Investigational Site 3011 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Zlin :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Denmark
Ã…rhus C : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Aalborg : Site Reference ID/Investigator# 61117
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Aalborg : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Aarhus :
A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis
Allerod : Noreba
Trial on Profermin and Fresubin in Ulcerative Colitis
View More »
Copenhagen : Site Reference ID/Investigator# 61118
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Herlev : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Hvidovre : Site Reference ID/Investigator# 61119
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Hvidovre : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Køge : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Odense : Odense University Hospital
Adalimumab in the Treatment of Chronic Pouchitis
Odense C : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Odense C : Odense University Hospital
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Estonia
Tallinn : ECG Unit, East Tallinn Central Hospital
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Tallinn : X-Ray Unit, East Tallin Central Hospital
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Tallinn : ECG Unit, East Tallinn Central Hospital
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Tallinn : X-Ray Unit, East Tallinn Central Hospital
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
Tallinn : Santarus Clinical Investigational Site 8001 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
View More »
Tallinn : Santarus Clinical Investigational Site 8002 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Tartu : Santarus Clinical Investigational Site 8003 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Finland
Lahti : Site Reference ID/Investigator# 63292
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
France
Caen Cedex 14 : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Grenoble Cedex 09 : Site Reference ID/Investigator# 61055
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Lille : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Lille Cedex : Site Reference ID/Investigator# 61059
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Nantes Cedex : Site Reference ID/Investigator# 61056
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
View More »
Nice Cedex 3 : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Paris cedex 12 : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Pessac Cedex : Site Reference ID/Investigator# 63463
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Pessac Cedex : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Reims : Site Reference ID/Investigator# 61057
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
St. Priest en Jarez : Site Reference ID/Investigator# 61063
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Toulouse Cedex 9 : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Vandoeuvre les Nancy : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Vandoeuvre les Nancy Cedex : Site Reference ID/Investigator# 63462
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Germany
Berlin : Research Site 501
A clinical research study for patients 18 or older with Ulcerative Colitis
Bottrop : Research Site 508
A clinical research study for patients 18 or older with Ulcerative Colitis
Freiburg : Research Site 509
A clinical research study for patients 18 or older with Ulcerative Colitis
Hannover : Research Site 504
A clinical research study for patients 18 or older with Ulcerative Colitis
Jena : Research Site 503
A clinical research study for patients 18 or older with Ulcerative Colitis
Muenster : Research Site 506
A clinical research study for patients 18 or older with Ulcerative Colitis
Regensburg : Research Site 507
A clinical research study for patients 18 or older with Ulcerative Colitis
Stade : Research Site 502
A clinical research study for patients 18 or older with Ulcerative Colitis
Ulm : Research Site 505
A clinical research study for patients 18 or older with Ulcerative Colitis
View More »
Berlin : Site Reference ID/Investigator# 61064
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Berlin : Charité Campus Benjamin Franklin, Medizinische Klinik I
Endomicroscopy in Ulcerative Colitis
Dachau : Site Reference ID/Investigator# 64222
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Erlangen : Department of Medicine I, University of Erlangen-Nuremberg
Endomicroscopy in IBD Patients
Hamburg : Site Reference ID/Investigator# 61069
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Hannover : Medizinishce Hochschule hannover
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Hannover :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Herne : Site Reference ID/Investigator# 61066
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Jena : Friedrich-Schiller-Universität Jena, Klinik für Innere Medizin II
Endomicroscopy in Ulcerative Colitis
Lübeck :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Mainz : Johannes Gutenberg-Universität Mainz, I. Med. Klinik und Poliklinik
Endomicroscopy in Ulcerative Colitis
Minden : Site Reference ID/Investigator# 61065
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Minden :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Muenster : Site Reference ID/Investigator# 61067
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Ulm : Universitaetsklinikum Ulm
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Ulm : Universitaetsklinikum Ulm
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
ULM :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Greece
Athens : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Haidari : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Heraklion : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Larissa : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Piraeus : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Hungary
Bekescsaba : Research Site 205
A clinical research study for patients 18 or older with Ulcerative Colitis
Budapest : Research Sites 204 and 207
A clinical research study for patients 18 or older with Ulcerative Colitis
Kaposvar : Research Site 203
A clinical research study for patients 18 or older with Ulcerative Colitis
Szekszard : Research Site 202
A clinical research study for patients 18 or older with Ulcerative Colitis
View More »
Bekescsaba : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Bekescsaba : Santarus Clinical Investigational Site 5010 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Budapest : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Budapest : Santarus Clinical Investigational Site 5008 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Budapest : Santarus Clinical Investigational Site 5009 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Budapest :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Debrecen : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Debrecen : Santarus Clinical Investigational Site 5001 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
GYR :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Gyula :
A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis
Gyula : Santarus Clinical Investigational Site 5003 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Kaposvar : Santarus Clinical Investigational Site 5004 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Miskolc : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Miskolc : Santarus Clinical Investigational Site 5002 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Mosonmagyarovar : Santarus Clinical Investigational Site 5006 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Pecs : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Pecs : Santarus Clinical Investigational Site 5011 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Szeged : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Szeged : Santarus Clinical Investigational Site 5005 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Szekszard : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Vac : Santarus Clinical Investigational Site 5007 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Ireland
Dublin 24 : Site Reference ID/Investigator# 65987
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Dublin 4 : Site Reference ID/Investigator# 65988
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Dublin 9 : Site Reference ID/Investigator# 65989
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Israel
Be'er Sheva : Soroka Medical Center
Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative Colitis
Haifa : Rambam Medical Center
Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative Colitis
Haifa :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Jerusalem : Site Reference ID/Investigator# 64204
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Jerusalem : Shaare Zedek Medical center
Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative Colitis
View More »
Jerusalem : Hadassah medical center
Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative Colitis
Jerusalem :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Petach Tikva : Site Reference ID/Investigator# 64206
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Ramat-gan :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Tel Aviv : Sourasky Medical Center
Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative Colitis
Tel Aviv :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Tel Hashomer : Site Reference ID/Investigator# 64202
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Italy
Bologna : Research Site 301
A clinical research study for patients 18 or older with Ulcerative Colitis
Rome : Research Sites 302 and 304
A clinical research study for patients 18 or older with Ulcerative Colitis
Torino : Research Site 303
A clinical research study for patients 18 or older with Ulcerative Colitis
View More »
Bologna : Site Reference ID/Investigator# 61112
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Bologna : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Crema : Ospedale Maggiore di Crema, Endoscopy and Gastroenterology Division
Endomicroscopy in Ulcerative Colitis
Firenze : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Milano : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Milano : European Institute of Oncology, Division of Endoscopy
Endomicroscopy in Ulcerative Colitis
Padova : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Palermo : Site Reference ID/Investigator# 61108
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Roma : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Rome : Site Reference ID/Investigator# 61104
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Rome : Site Reference ID/Investigator# 61115
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Rozzano : Site Reference ID/Investigator# 61111
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Rozzano MI : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Japan
Chikushino : Fukuoka University Chikushi Hospital
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Chikushino : Fukuoka University Chikushi Hospital
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
Hokkaido : Sapporo higashi tokushukai hospital
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Osaka : Osaka City University Hospital
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Sapporo : Hokkaido P.W.F.A.C Sapporo-Kosei general Hospital
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
View More »
Sapporo : Hokkaido P.W.F.A.C Sapporo-Kosei general Hospital
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Sendai : National Hospital Organization Sendai Medical Center
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Sendai : National Hospital Organization Sendai Medical Center
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Takatsuki-shi : Osaka Medical College Hospital
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Takatsuki-shi : Osaka Medical College Hospital
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Latvia
Riga : Santarus Clinical Investigational Site 8101 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Riga : Santarus Clinical Investigational Site 8103 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Riga : Santarus Clinical Investigational Site 8102 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Lithuania
Kaunas : Lexicon Investigational Site
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Kaunas : Santarus Clinical Investigational Site 8202 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Klaipeda : Lexicon Investigational Site
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Siauliai : Lexicon Investigational Site
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Vilnius : Lexicon Investigational Site
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
View More »
Vilnius : Santarus Clinical Investigational Site 8203 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Vilnius : Santarus Clinical Investigational Site 8201 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Netherlands
Amsterdam : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Maastricht : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
New Zealand
Auckland :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Christchurch :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Tauranga : Clinical Trials Unit, BOP Clinical School, Bay of Plenty District Health Board
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Tauranga : Clinical Trials Unit, BOP Clinical School, Bay of Plenty District Health Board
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Norway
Hamar : Site Reference ID/Investigator# 62364
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Oslo : Site Reference ID/Investigator# 62362
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Oslo : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Tromsø : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Poland
Krakow : Research Site 604
A clinical research study for patients 18 or older with Ulcerative Colitis
Lodz : Research Site 605
A clinical research study for patients 18 or older with Ulcerative Colitis
Warszawa : Research Sites 601, 602, 603
A clinical research study for patients 18 or older with Ulcerative Colitis
View More »
Elblag : Santarus Clinical Investigational Site 6003 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Katowice :
A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis
Krakow : Lexicon Investigational Site
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Krakow : Santarus Clinical Investigational Site 6001 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Lodz : Lexicon Investigational Site
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Lublin : Klinika Pediatrii Dzieciecy Szpital Kliniczny im prof Antoniego Gebali
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
Rzeszow : Kliniczny Oddzial Pediatrii z Pododdzialem Neurologii Dzieciecej Szpital Wojewodzki
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
Rzgowska : Klinika Gastroenterolofii Pediatrii, Instytut Centrum Zdrowia Matki Polki
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
Sopot : Lexicon Investigational Site
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Sopot : Santarus Clinical Investigational Site 6002 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Szczecin : Santarus Clinical Investigational Site 6006 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Warszawa : Lexicon Investigational Site
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Warszawa : Santarus Clinical Investigational Site 6008 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Warszawa : Santarus Clinical Investigational Site 6004 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Warszawa : Oddzial Gastroenterologii i Hepatologii, Instytut Pomnik-Centrum Zdrowia Dziecka
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
Warszawy : Santarus Clinical Investigational Site 6005 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Wieliczka : Klinika Pediatrii Gastroenterologii i Zywienia, Uniwersytecki Szpital Dzieciecy w Krakowie
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
Wroclaw : Lexicon Investigational Site
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Portugal
Faro : Site Reference ID/Investigator# 61100
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Lisbon : Site Reference ID/Investigator# 61101
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Porto : Site Reference ID/Investigator# 61098
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Puerto Rico
Ponce : Pharmaseek, LLC
Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
Russian Federation
Moscow :
A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis
Moscow : Santarus Clinical Investigational Site 9010 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Moscow : Santarus Clinical Investigational Site 9005 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Nizhny Novgorod : Santarus Clinical Investigational Site 9004 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Ryazan : Santarus Clinical Investigational Site 9003 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
View More »
Saint Petersburg : Santarus Clinical Investigational Site 9008 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Saratov : Santarus Clinical Investigational Site 9009 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
St Petersburg : Santarus Clinical Investigational Site 9001 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Stavropol : Santarus Clinical Investigational Site 9007 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Ufa : Santarus Clinical Investigational Site 9006 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Slovakia
Banska Bystrica : DFNsP Banska Bystrica
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
Limbova 2 : Gastroenterologicka ambulancia
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
Martin : Univerzitna nemocnica Martin
Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis
Nitra : Jessenius - diagnosticke centrum a.s.
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Nitra : Kardiocentrum Nitra s.r.o.
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
View More »
Nitra : KM Management spol. s.r.o.
A Study Of Oral CP-690550 As A Maintenance Therapy For Ulcerative Colitis
Nitra : Lexicon Investigational Site
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Nitra : Kardiocentrum Nitra s.r.o.
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
Nitra : KM Management spol. s.r.o.
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
Nitra : Jessenius - diagnosticke centrum a.s.
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
Nove Mesto nad Vahom : Lexicon Investigational Site
A Study to Evaluate Safety and Efficacy of LX1606 in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Spain
Badalona - Barcelona : Site Reference ID/Investigator# 61087
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Barcelona : Site Reference ID/Investigator# 61083
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Barcelona : Site Reference ID/Investigator# 61086
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Cordoba : Site Reference ID/Investigator# 61085
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Madrid : Site Reference ID/Investigator# 61082
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
View More »
Madrid : Site Reference ID/Investigator# 63988
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Santiago de Compostela : Site Reference ID/Investigator# 61088
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Sweden
Linkoping : Site Reference ID/Investigator# 61073
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Lund : Site Reference ID/Investigator# 61072
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Skovde : Site Reference ID/Investigator# 65583
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Stockholm : Site Reference ID/Investigator# 65586
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Stockholm : Södersjukhuset
A Study to Evaluate a Leukapheresis Treatment in Patients With Ulcerative Colitis
Switzerland
Basel : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Bern : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
St. Gallen : Site Reference ID/Investigator# 66183
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Zurich : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Ukraine
Crimea : Santarus Clinical Investigational Site 7010 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Donetsk : Santarus Clinical Investigational Site 7002 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Kharkiv : Santarus Clinical Investigational Site 7004 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Kharkiv : Santarus Clinical Investigational Site 7001 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Kyiv : Santarus Clinical Investigational Site 7006 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
View More »
Kyiv : Santarus Clinical Investigational Site 7008 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
Odessa :
A Placebo-controlled Trial With rFXIII Administered to Subjects With Mild to Moderate Active Ulcerative Colitis
Vinnytsia : Santarus Clinical Investigational Site 7005 Updated
Randomized Placebo Controlled Trial of Budesonide MMX® 9 mg in Patients With Ulcerative Colitis Currently on a 5-ASA
United Kingdom
London : Research Site 102
A clinical research study for patients 18 or older with Ulcerative Colitis
Norwich : Research Site 103
A clinical research study for patients 18 or older with Ulcerative Colitis
Nottingham : Research Site 101
A clinical research study for patients 18 or older with Ulcerative Colitis
View More »
Birmingham :
A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160)
Birmingham : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Blackpool : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Coventry :
A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160)
Gloucester : Site Reference ID/Investigator# 62367
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Liverpool :
A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160)
Liverpool : Royal Liverpool University Hospital
Rituximab in Ulcerative Colitis
London : Site Reference ID/Investigator# 62567
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
London : Research Site Updated
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Newcastle Upon Tyne :
Study to Evaluate the Long-term Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Oxford : Site Reference ID/Investigator# 61046
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Southampton : Site Reference ID/Investigator# 62568
A Multicenter Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Wigan :
A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160)
Worthing : Worthing Hospital
Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1)